Skip to main content
. Author manuscript; available in PMC: 2020 Aug 26.
Published in final edited form as: Neuroscience. 2019 Jul 24;415:173–183. doi: 10.1016/j.neuroscience.2019.07.030

Figure 4. Differential mRNA expression of fgfr1 and fgfr2 in the NAc and dorsal striatum after withdrawal from oxycodone.

Figure 4.

(A-B) fgfr1 and (C-D) fgfr2 mRNA levels showed no significant changes in the NAc. (E-F) Striatal fgfr1 mRNA levels are decreased in all oxycodone rats. (G-H) Striatal fgfr2 mRNA expression showed dose-dependent increases in LgA-L and LgA-H rats. The values in the bar graphs represent means ± SEM (n=5–15 animals per group). Note the differences in the scales in the Y-axis in G and H for fgfr2 expression in comparison to others. Key to statistics: **, *** = p < 0.01, 0.001, respectively, in comparison to saline rats.